TARO PHARMACEUTICALS INC. — Doxorubicin Importer Profile
Pharmaceutical Importer · #1 buyer for Doxorubicin · $550.0K import value · 11 shipments · CANADA · DGFT Verified
TARO PHARMACEUTICALS INC. is the #1 importer of Doxorubicin from India with $550.0K in import value and 11 verified shipments. TARO PHARMACEUTICALS INC. holds a 0.7% market share in Doxorubicin imports based in CANADA. The company sources from 1 verified supplier across 9 formulations shipped to 1 country. Overall, TARO PHARMACEUTICALS INC. imports 12 pharmaceutical products worth $6.8M across 6 therapeutic categories.
TARO PHARMACEUTICALS INC. — Doxorubicin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Doxorubicin to TARO PHARMACEUTICALS INC.?
Verified from 11 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $550.0K | 11 | 100.0% |
TARO PHARMACEUTICALS INC. sources Doxorubicin from 1 verified Indian supplier based on 11 customs records. The primary supplier is SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 100.0% of imports.
How Does TARO PHARMACEUTICALS INC. Compare to Nearest Doxorubicin Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | RXCROSSROADS 3PL LLC | UNITED STATES | $600.0K | 12 | $50.0K |
| 8 | SUN PHARMACEUTICAL INDUSTRIES INC., | UNITED STATES | $550.0K | 11 | $50.0K |
| 1 | TARO PHARMACEUTICALS INC. ★ | CANADA | $500.0K | 10 | $50.0K |
| 10 | SUN PHARMA ANZ PTY LTD | AUSTRALIA | $350.0K | 7 | $50.0K |
| 9 | DR REDDYS LABORATORIES INC | UNITED STATES | $300.0K | 6 | $50.0K |
TARO PHARMACEUTICALS INC. ranks #1 among 899 Doxorubicin importers from India. Average shipment value of $50.0K compared to the market average of $8.1K. The closest competitors by value are RXCROSSROADS 3PL LLC and SUN PHARMACEUTICAL INDUSTRIES INC.,.
Where Does TARO PHARMACEUTICALS INC. Import Doxorubicin To?
Destination countries from 11 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $550.0K | 11 | 100.0% |
TARO PHARMACEUTICALS INC. imports Doxorubicin to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $550.0K.
What Doxorubicin Formulations Does TARO PHARMACEUTICALS INC. Import?
| Formulation | Value | Shipments |
|---|---|---|
| TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOME | $150.0K | 3 |
| TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [3631 PACKX 1 VIAL] | $50.0K | 1 |
| TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION 20MG/10ML (2MG/ML) [3427 PACKX 1 VIAL]VLS | $50.0K | 1 |
| TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION 20MG/10ML (2MG/ML) [3558 PACKX 1 VIAL]VLS | $50.0K | 1 |
| TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [1756 PACKX 1 VIAL] | $50.0K | 1 |
| TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [3586 PACKS X 1 VIAL] | $50.0K | 1 |
| TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [3415 PACKX 1 VIAL] | $50.0K | 1 |
| TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [10516 PACK X 1 VIAL] | $50.0K | 1 |
| TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION, 20MG/10ML (2MG/ML) [7082 PACKX 1 VIAL] | $50.0K | 1 |
TARO PHARMACEUTICALS INC. imports 9 distinct Doxorubicin formulations from India. The top formulation is TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOME with 3 shipments worth $150.0K.
Regulatory Requirements: Importing Doxorubicin into Canada
What TARO PHARMACEUTICALS INC. and other importers must comply with to import Doxorubicin from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Doxorubicin
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Doxorubicin from India and How Much Does TARO PHARMACEUTICALS INC. Import?
India exported $7.3M worth of Doxorubicin through 3,492 shipments from 310 suppliers to 136 countries, serving 899 buyers globally. TARO PHARMACEUTICALS INC. imports $550.0K of this total, accounting for 0.7% of India's Doxorubicin exports with 11 shipments from CANADA. This is verified from 11 customs shipment records covering 9 distinct formulations.
What Is the Average Order Value for TARO PHARMACEUTICALS INC.'s Doxorubicin Imports?
TARO PHARMACEUTICALS INC.'s average Doxorubicin order value is $50.0K per consignment, based on 11 shipments totaling $550.0K. TARO PHARMACEUTICALS INC. is based in CANADA and ranks #1 among all Doxorubicin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Doxorubicin to TARO PHARMACEUTICALS INC.?
TARO PHARMACEUTICALS INC. sources Doxorubicin from 1 verified Indian supplier: SUN PHARMACEUTICAL INDUSTRIES LIMITED ($550.0K, 100.0%). This is based on 11 customs records.
How Does TARO PHARMACEUTICALS INC. Compare to Other Doxorubicin Importers?
TARO PHARMACEUTICALS INC. ranks #1 among 899 Doxorubicin importers from India with a 0.7% market share. The top 3 importers are DR REDDYS LABORATORIES,INC ($1.1M), SUN PHARMACEUTICAL INDUSTRIES INC ($1.1M), SUN PHARMACEUTICAL INDUSTRIES,INC. ($850.0K). TARO PHARMACEUTICALS INC. processed 11 shipments from CANADA.
About TARO PHARMACEUTICALS INC.
TARO PHARMACEUTICALS INC. imports 12 products worth $6.8M. Beyond Doxorubicin, top products include Temozolomide, Sunitinib, Budesonide, Dasatinib, Capecitabine. View the complete TARO PHARMACEUTICALS INC. profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Doxorubicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Doxorubicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TARO PHARMACEUTICALS INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TARO PHARMACEUTICALS INC.'s capped import value divided by total capped export value for Doxorubicin across all Indian exporters.
- 5.Verified Records: This page is backed by 11 individual customs records matching TARO PHARMACEUTICALS INC. importing Doxorubicin, covering 9 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 136+ countries, 899+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Doxorubicin Import Data for TARO PHARMACEUTICALS INC.
Access order-level details, pricing data, supplier connections, and competitive analysis for TARO PHARMACEUTICALS INC.'s Doxorubicin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TARO PHARMACEUTICALS INC.
Full Company Profile →
12 products · $6.8M total trade · 6 categories
TARO PHARMACEUTICALS INC. × Doxorubicin
Verified from customs records
Company Overview
Top Products by TARO PHARMACEUTICALS INC.
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TARO PHARMACEUTICALS INC..
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Doxorubicin. For current order-level data, contact TransData Nexus.